Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targretin dose comparison in refractory CTCL
NCT01007448Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jan 2010
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bexarotene in cutaneous T-cell lymphoma (CTCL), sponsored by Valeant Pharmaceuticals. Started Jan 2010; status: completed.
02
Drugs
bexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT01007448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007448.